18
Besides the expansion of its fermentation capacity to 5,000L, the CDMO added a state of the art process development laboratory to its new production site in Vilnius investing more than €50m.
Dr. Vladas Bumelis, Chairman of the Board of Biotechpharma UAB, stated, The expansion comes amid growing global demand for flexible and responsive outsourcing partners that are able to support the full product lifecycle, from upstream and downstream process development and optimization to GMP manufacturing of drug substance and formulated drug product.
Demand in mammalian cell-based and microbial production of biologics has been grown along with the…